Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIIB Study of IGF-I Monitoring in Children Treated With NutropinAq
2004-000356-17Phase 3
- Sponsor
- Ipsen
- Start
- Jun 2004
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of somatropin in faltering growth (FTT), sponsored by Ipsen.
02
Drugs
somatropin
03
Conditions
faltering growth (FTT)
Beyond the preview
Go deeper on 2004-000356-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-000356-17.